
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
To promote breastfeeding after a mother returns to work, pediatricians need to make knowledgeable recommendations about which breast pump to use and provide guidelines to ensure proper milk storage.






